Peer Group

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 13,671.73 833.94 205.45 -200.00 32.19 0.02 13.4593 -0.42 -108.9858 -2,428.2283 -9.34 -8.82 799.1504 - -
Maximum - - - - - - 593,913.00 65,349.00 25,407.00 99,050.00 5,305.00 0.94 1,336.3467 6.70 300.5100 8,534.8500 38.40 835.37 6,156.2100 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -10,177.5800 -144,478.0000 -155.91 -1,263.79 0.0700 - -
Amphastar Pharmaceuticals, Inc. AMPH 50.11 0.33 0.66% 25 vs. 392 2,439.00 171.00 43.00 46.00 452.00 0.9000 12.1264 0.00 50.80 25.13 6.42 2.74 168.56 48.00
Alkermes plc ALKS 28.14 0.31 1.11% 96 vs. 1,784 4,633.00 350.00 36.00 12.00 -1,306.00 0.2200 31.0625 0.00 82.56 10.51 2.94 1.73 231.41 164.00
Neurocrine Biosciences, Inc. NBIX 122.31 2.46 2.06% 49 vs. 925 12,350.00 515.00 43.00 119.00 -113.00 0.4300 81.2772 0.00 97.52 8.42 1.82 1.25 233.03 100.00
Intra-Cellular Therapies, Inc. ITCI 75.79 1.09 1.46% 43 vs. 944 8,008.00 144.00 -15.00 -34.00 -1,632.00 -0.1600 -108.4422 0.00 93.17 -10.52 -2.54 -2.04 451.43 105.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for ALKS and its peers to uncover potential buy and sell opportunities.